If a patient is deficient or following a reduced-calorie plan, consistent support may make more sense than occasional use
Tirzepatide is a dual-agonist (GLP-1 + GIP)
At the same time, peptides are also deeply embedded in the broader longevity space, where the focus is not simply symptom management but improving function over time
Moreover, semaglutide impacts hunger-related hormones by lowering the production of ghrelin, the hunger hormone, effectively reducing the sensation of hunger
We're going to unpack today what's driving the race for scale and what it means for investors and the industries at large
A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome